Skip to main content
Evidence-Based Therapy
Mind-Body & Cycle Practice

CBT for Insomnia

A structured talk therapy program that improves sleep during menopause by changing sleep habits and unhelpful thoughts about sleep.

Last updated:

CBT for Insomnia
Method at a Glance
EfficacyN/Atypical use
Duration6-8 sessions over 8 weeks
Cost$0–$200/one-time
ReversibilityReversible
STI ProtectionNo
ProviderClinical psychologists, behavioral sleep medicine specialists, CBT-trained therapists
Clinical Reference

Full clinical details

Efficacy data, safety profile, regulatory status, and research evidence for this method class.

Efficacy Profile
N/A

MsFLASH CBT-I Trial (n=106, 8-week RCT): Insomnia Severity Index (ISI) decreased 9.9 points with telephone-based CBT-I vs 4.7 with menopause education control (between-group difference 5.2 points, P<.001). At 8 weeks, 70% of CBT-I participants had ISI scores in the no-insomnia range vs 24% of controls; at 24 weeks, 84% vs 43%. Pittsburgh Sleep Quality Index also improved significantly (4.0 vs 1.4 point decrease, P<.001). The source reports absolute score reductions on the ISI (0-28 scale), not a percentage. A 2024 meta-analysis of 11 RCTs (n=973) confirmed CBT-I significantly improves sleep quality and reduces insomnia severity in menopausal women regardless of delivery mode. NAMS 2023 recommends CBT (Level I) and notes CBT-I specifically helps women with VMS and insomnia.

Cost & Insurance
$0–$200/one-time

Cost varies widely. Self-guided digital CBT-I programs (e.g., Sleepio, Somryst) may be free through insurance or $30-$50/month. In-person or telehealth CBT-I with a trained therapist typically costs $100-$200 per session, with 6-8 sessions standard. Many insurance plans cover CBT-I when delivered by a licensed provider.

Insurance CoverageUsually
Duration & Reversibility
Typical Lifespan6-8 sessions over 8 weeks
Reversibility
Reversible
STI ProtectionNo
How It Works
Biological Mechanism

Cognitive Behavioral Therapy for Insomnia (CBT-I) combines sleep restriction (limiting time in bed to build sleep drive), stimulus control (associating the bed only with sleep), sleep hygiene education, cognitive restructuring (challenging unhelpful beliefs about sleep), and relaxation techniques. It targets the behavioral and cognitive patterns that maintain insomnia, rather than using medication.

Regulatory Details
FDA Regulatory StatusEvidence-Based Therapy
Prescription RequiredOTC
Provider TypeClinical psychologists, behavioral sleep medicine specialists, CBT-trained therapists
Supporting Your Body & What to Expect
  • Temporary daytime sleepiness during initial sleep restriction phase
  • Short-term increase in fatigue as sleep window is narrowed
Safety & Suitability
  • Untreated sleep apnea (address apnea first)
  • Active mania or psychosis (CBT-I is not appropriate during acute psychiatric crises)
  • Shift work sleep disorder (CBT-I is designed for chronic insomnia, not circadian rhythm disorders)
Clinical Guidelines
NAMS

2023 Position Statement - CBT recommended (Level I); CBT-I specifically helps women with VMS and insomnia

View Guideline
American College of Physicians

CBT-I is first-line treatment for chronic insomnia (ACP 2016 Guideline)

View Guideline
Editorial Curation

Clinical Commentary & Context

What it is

Cognitive Behavioral Therapy for Insomnia (CBT-I) is a structured, evidence-based talk therapy for chronic insomnia. Unlike sleep medications, which temporarily induce sleep, CBT-I targets the behaviors and thought patterns that keep insomnia going. A typical program runs 6 to 8 sessions and includes five core components: sleep restriction (temporarily limiting time in bed to build sleep drive), stimulus control (associating the bed only with sleep), sleep hygiene education, cognitive restructuring (challenging unhelpful beliefs like “I’ll never sleep again”), and relaxation techniques. CBT-I can be delivered in person, by telephone, or through digital programs.

How well it works

The strongest evidence for CBT-I in menopausal women comes from the MsFLASH CBT-I Trial (JAMA Internal Medicine, 2016), a randomized clinical trial of 106 perimenopausal and postmenopausal women with insomnia and hot flashes. After 8 weeks of telephone-based CBT-I, Insomnia Severity Index scores dropped by 9.9 points, compared to 4.7 points in the menopause education control group, a statistically significant difference (P<.001). At 8 weeks, 70% of CBT-I participants had ISI scores in the no-insomnia range, compared to 24% of controls. Improvements were sustained at 24 weeks, with 84% of CBT-I participants in the no-insomnia range versus 43% of controls. A 2024 meta-analysis of 11 RCTs (n=973) confirmed that CBT-I significantly improves sleep quality and reduces insomnia severity in menopausal women, regardless of whether it is delivered face-to-face, by telephone, or online.

The Menopause Society (NAMS 2023) recommends cognitive behavioral therapy as a Level I intervention (good and consistent scientific evidence) and notes that women with vasomotor symptoms and insomnia benefit from CBT for insomnia. The American College of Physicians recommends CBT-I as first-line treatment for chronic insomnia in all adults, ahead of sleep medications.

Side effects and cautions

CBT-I does not involve medication, so it has no drug side effects. The main challenge is temporary daytime sleepiness during the first 1 to 2 weeks, when sleep restriction narrows the time in bed to rebuild sleep drive. This is intentional and resolves as sleep consolidates. CBT-I is not appropriate for people with untreated sleep apnea (which should be addressed first), those in an acute manic or psychotic episode, or people with shift work sleep disorder, which is a circadian rhythm disorder rather than chronic insomnia.

Where to get it

CBT-I is delivered by clinical psychologists, behavioral sleep medicine specialists, and CBT-trained therapists. It is available in person, via telehealth, and through digital programs. Some insurance plans cover CBT-I when provided by a licensed clinician. Self-guided programs like Sleepio and Somryst are available online and may be free through certain health plans.

Research Pipeline

Active & Completed Clinical Studies

Track the scientific evidence and progress of clinical trials backing this method.

N/ACompleted

MsFLASH CBT-I Trial

Registry ID: NCT01936441